baber/WOPTO huggingface dataset:
Patent AU-2021265297-A1 (AU)
Title: Tailless knotter for baler
Inventor: BECKER DAVID
IPC: A01F15/14
Filed: 2021-04-09
Abstract: A knotter assembly (40) is operable to produce two successive knots (70,68) in a pair of strands of binding material during one full operating cycle of the knotter assembly to secure a formed bale. The knotter assembly includes a billhook (82) configured to perform at least a first full rotation around its rotation axis during formation of a first (70) of the knots and a second full rotation around its rotation axis (228) during formation of a second (68) of the knots. The knotter assembly includes a twine holder (87) and a cutter (94) co-operating with the twine holder (87) for severing the strands during formation of the first one of the successive knots. The knotter assembly (40) includes twine discs having a plurality of notches (200) spaced around the outer circumference, the plurality of notches (200) including a first set of notches having a first shape and a second set of notches having a second shape different than the first shape.
Patent AU-2021272903-A1 (AU)
Title: Compositions and methods related to megakaryocyte-derived extracellular vesicles
Inventor: THON JONATHAN
IPC: A61K9/127
Filed: 2021-05-11
Abstract: Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for drug delivery and treating various diseases.
Patent AU-2021313398-A1 (AU)
Title: Use of Alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex I deficiencies
Inventor: PROCACCIO VINCENT
IPC: A61P9/00
Filed: 2021-07-26
Abstract: The present invention relates to the use of Alverine or one of its derivatives for treating diseases associated with mitochondrial dysfunction, especially with mitochondrial complex I deficiency.
Patent AU-2021327387-A1 (AU)
Title: Fgfr3 antibodies and methods of use
Inventor: SABBAGH YVES
IPC: C07K16/28
Filed: 2021-08-20
Abstract: Anti-FGFR3 antigen-binding proteins and antigen-binding binding fragments thereof are provided. Methods of inhibiting FGFR3 activity and methods of treating FGFR3-mediated diseases and disorders are also provided.
Patent AU-2021330539-A1 (AU)
Title: Treatment of non-small cell lung cancer with egfr mutations
Inventor: KNOBLAUCH ROLAND
IPC: A61K33/24
Filed: 2021-08-25
Abstract: The present invention relates to treatment of subjects having EGFR exon 20 insertion and other uncommon EGFR mutations.
Patent AU-2021332957-A1 (AU)
Title: Depolymerization of polyurethanes under mild conditions
Inventor: HILDEBRAND JENS
IPC: C08J11/28
Filed: 2021-07-02
Abstract: The present invention relates to an improved process for depolymerization of polyurethanes under mild conditions, wherein polyether polyols and polyamines can be recovered in high yields.
Patent AU-2021336788-A1 (AU)
Title: In vivo lymphovenous anastomosis
Inventor: SEN CHANDAN K
IPC: C12N5/10
Filed: 2021-08-31
Abstract: Disclosed herein are compositions and
Patent AU-2021353150-A1 (AU)
Title: Power control system and program
Inventor: NAKAGAWA YOSHIHIRO
IPC: H02J13/00
Filed: 2021-08-13
Abstract: [Problem] In the case of controlling the power consumption by a group composed of a plurality of power consumption units, to adjust the control for each power consumption unit, in accordance with the power usage status of each power consumption unit for each time, and reduce unused power for the entire group. [Solution] Provided is a system which controls power so as not to exceed a target power set for a group composed of a plurality of power consumption units, and comprises: a limit value setting unit 330 which on the basis of the target power, sets the limit value of the power consumption for a predetermined time, for each power consumption unit; and a limit value adjusting unit 370 which adjusts the limit value of the power consumption unit in the predetermined time, on the basis of the actual power consumption in the predetermined time, within the predetermined time.
Patent AU-2021359750-A1 (AU)
Title: Additive manufacturing device, method, and medical product relating thereto
Inventor: LEONHARDT STEFAN
IPC: B22F10/00
Filed: 2021-10-12
Abstract: The invention relates to an additive manufacturing device (14), in particular a 3D printer, for manufacturing at least one component (10) formed layer by layer, the device comprising: at least one construction chamber (16); at least one extrusion head (18) that is three-dimensionally movable inside the construction chamber (16); and at least one open-loop and/or closed-loop control device for open-loop and/or closed-loop control of the extrusion head (18); wherein the open-loop and/or closed-loop control device is designed for open-loop and/or closed-loop control of the extrusion head (18) such that at least one material layer (12.1) of the component (10) can be formed by the extrusion head (18) by forming one or more infill material strands (12a), in particular in at least one first two-dimensional plane, such that at least one second material layer (12.2) of the component (10) can be formed by the extrusion head (18) by forming one or more infill strands (12a) building on the first material layer (12.1), in particular in at least one second two-dimensional plane parallel to the first two-dimensional plane, and such that the first and/or second material layer (12.2) can be formed by the extrusion head (18) in each case exclusively by the one or the plurality of infill material strands (12a). The invention further relates to an additive manufacturing method, in particular a 3D printing method, for a component (10) made of a plurality of material layers (12.1, 12.2) and to a component produced by the additive manufacturing method according to the invention.
Patent AU-2021373322-A1 (AU)
Title: Hermetically connected arrangement, enclosure and method for the production thereof
Inventor: THOMAS JENS ULRICH
IPC: H01L23/10
Filed: 2021-11-08
Abstract: The invention discloses a hermetically connected arrangement comprising a first metallic substrate, a second substrate, at least certain regions of which and/or at least parts of which are designed to be transparent in respect of at least one wavelength range, wherein the first substrate is arranged with a contact surface adjacent to a contact surface of the second substrate, and also having at least one laser-joining line or a plurality of points of attachment for joining the first metallic substrate directly to the second substrate, on or in the contact surfaces, wherein the laser-joining line or the plurality of points of attachment, on the one hand, extends/extend into the first substrate and, on the other hand, extends/extend into the second substrate and fuses/fuse the at least two substrates directly to one another.
Patent AU-2021386376-A1 (AU)
Title: Forearm assessment and training devices, systems, kits, and methods
Inventor: MOREAU DARYL
IPC: A61B5/00
Filed: 2021-11-24
Abstract: A forearm assessment and training device has a main support, a plurality of finger motion transmission members, a plurality of finger receivers, and a control module. Each of the finger motion transmission members has a member body with a first end and a second end. The first end of the member body of each of the finger motion transmission members is connected to the main support. Each of the finger receivers is connected to the member body of one of the finger motion transmission members. Each of the finger receivers has a finger aperture. The control module is connected to the main support. The control module includes a control module processor, a control module memory, and a sensor. The sensor is configured to measure a force applied to at least one of the finger motion transmission members.
Patent AU-2021388842-A1 (AU)
Title: Methods for ensuring resuspension of paliperidone palmitate formulations
Inventor: D'HOORE PETER
IPC: A61K9/00
Filed: 2021-11-24
Abstract: Provided are methods for improving resuspendability of a paliperidone palmitate extended-release injectable suspension within a syringe, for reducing a force required for injection of a paliperidone palmitate extended-release injectable suspension, or for reducing the likelihood of incomplete injection of a paliperidone palmitate extended-release injectable suspension comprising maintaining the syringe in a desired orientation during shipping of the syringe that varies from the orientation of the syringe during pre-shipping storage. Also provided are populations of syringes that respectively contain paliperidone palmitate extended release injectable suspension, wherein each of the syringes have been shipped to a destination, and the syringes were each maintained in a desired orientation during shipping of the syringe that varies from the orientation of the syringe during pre-shipping storage. The present disclosure also provides pharmaceutical products comprising a paliperidone palmitate extended-release injectable suspension within a syringe for administration to a patient suffering from schizophrenia, wherein the syringe has undergone pre-shipping storage and has been shipped, and wherein the syringe has been maintained in an orientation during the shipping that varies from the orientation of the syringe during pre-shipping storage.
Patent AU-2021444377-A1 (AU)
Title: Ceramic composite
Inventor: STEINMETZ MOSHE
IPC: B28B5/00
Filed: 2021-05-04
Abstract: A composite ceramic element is provided in which the individual ceramic elements are passed on rollers and fired in a kiln, glazed and subsequently secured together.
Patent WO-2022192957-A1 (WO)
Inventor: CHEN YING
IPC: H01M4/04
Filed: 2022-03-17
Abstract: L'invention concerne des électrodes auxquelles sont associés un film poreux de protection ou un revêtement de nanotubes de nitrure de bore (BNNT).
Patent WO-2023023785-A1 (WO)
Inventor: AGUIRRE GUTIERREZ VICTOR JESUS
IPC: G02B7/00
Filed: 2022-08-25
Abstract: Un agencement de caméra chirurgicale à port frontal comprenant un serre-tête adapté pour être porté par un utilisateur. Au moins un objectif de caméra orienté vers l'avant est situé sur un côté avant du serre-tête et un objectif de caméra orienté vers l'arrière est situé sur un côté arrière du serre-tête. L'objectif de la caméra orientée vers l'avant et l'objectif de la caméra orientée vers l'arrière sont connectés de manière opérationnelle à une commande électronique, ce qui permet de transmettre à la commande électronique des données vidéo et/ou audio enregistrées provenant de l'au moins un objectif de caméra orientée vers l'avant et de l'objectif de caméra orientée vers l'arrière.
Patent AU-2022201410-A1 (AU)
Title: Peptide construct having a protease-cleavable linker
Inventor: CROWE SCOTT
IPC: A61P37/00
Filed: 2022-03-01
Abstract: There is provided inter alia a construct suitable for oral administration comprising a first 
polypeptide and a second polypeptide connected by a labile peptide linker, wherein the labile 
5 peptide linker is labile to one or more proteases present in the intestinal tract and wherein the 
first and second polypeptides are substantially resistant to said one or more proteases.
Patent AU-2022201848-A1 (AU)
Title: Pharmaceutical resinate compositions and methods of making and using thereof
Inventor: SADATREZAEI MOHSEN
IPC: A61K31/00
Filed: 2022-03-16
Abstract: Pharmaceutical compositions having a mixture of at least one active agent, an ion exchange resin, a binder, 
and a matrix material such that the composition, when administered to a patient in need thereof, provides 
the patient with a therapeutic effect for at least about 8 hours and related methods. Also disclosed herein 
are methods of preparing said pharmaceutical compositions having a mixture of a drug susceptible to 
abuse, a non-opioid analgesic and an ion exchange resin, the compositions further comprising binding 
agents and the like.
Patent AU-2022214843-A1 (AU)
Title: Mutations in canine antibody constant regions
Inventor: CAMPOS HENRY
IPC: C07K16/00
Filed: 2022-01-27
Abstract: The invention relates generally to canine antibody variants and uses thereof. Specifically, the invention relates to mutations in the constant region of canine antibody for improving various characteristics.
Patent AU-2022224389-A1 (AU)
Title: Apparatus and Method for Treating Gas and Air-conditioning Device
Inventor: SEDLAK HOLGER
IPC: F25B9/00
Filed: 2022-02-17
Abstract: The invention relates to a device for processing gas, comprising the following features: a compressor (40), which has a compressor inlet (41) and a compressor outlet (42); a heat exchanger (10), which has a heat exchanger inlet (11), a first heat exchanger outlet (12), a second heat exchanger inlet (13) and a second heat exchanger outlet (14), the heat exchanger being in the form of a gas-to-gas heat exchanger; a turbine (70), which has a turbine inlet (71) and a turbine outlet (72), the compressor outlet (42) being connected to the second heat exchanger inlet (13), and the second heat exchanger outlet (14) being connected to the turbine inlet (71); an inlet interface for coupling the compressor inlet (41) and the first heat exchanger inlet (11) to a gas feed; and an outlet interface (200) for coupling the turbine outlet (72) and the first heat exchanger outlet (12) to a gas discharge.
Patent AU-2022226318-A1 (AU)
Title: System and method for high efficiency filtering and removal of airborne pathogens from a volume of gas
Inventor: BOYD CLARK
IPC: B01D5/00
Filed: 2022-02-28
Abstract: A system and method for removing unwanted particles and pathogens, including but not limited to viruses, from a volume of gas. The system exhibits low resistance to air flow, allowing a high volume flow and rate of gas volume to be processed. Cold surfaces reduce the temperature of incoming gas causing condensation of water from the gas. The condensate contains unwanted particles and pathogens that have been removed from the volume of gas. The condensate is caused to pass over heated surfaces that comprising a hydrophobic coating, and also comprising catalytic surfaces with anti-viral coatings to neutralize contagions. Micro- spray nozzles, which may incorporate ionization, may be utilized to spray collected water onto the heated surfaces where the contagion may be utilized. The system may comprise multiple stages. The system provides better contagion neutralization and higher flow rates than prior art systems while using less energy, and producing less noise.
Patent AU-2022231733-A1 (AU)
Title: Systems and methods for mobile device analysis of nucleic acids and proteins
Inventor: GOEL ANITA
IPC: B01L3/00
Filed: 2022-09-15
Abstract: OF THE DISCLOSURE 
A portable system for extracting, optionally amplifying, and detecting nucleic acids or 
proteins using a compact integrated chip in combination with a mobile device system for 
analyzing detected signals, and comparing and distributing the results via a wireless network.  
Related systems and methods are provided.
Patent AU-2022252850-A1 (AU)
Title: Lysin Polypeptides Active Against Gram-Negative Bacteria
Inventor: SCHUCH RAYMOND
IPC: A61K38/16
Filed: 2022-10-14
Abstract: FIGURE 4.  
A Aeginaossrain PA01 
The present disclosure provides methods and compositions useful for the prophylactic and 
therapeutic amelioration and treatment of infections caused by Gram-negative bacteria, 
including Pseudomonas aeruginosa. The disclosure further provides compositions and methods 
of incorporating and utilizing lysin polypeptides of the present disclosure for augmenting the 
efficacy of antibiotics generally suitable for the treatment of Gram-negative bacterial infection.
Patent AU-2022270919-A1 (AU)
Title: Sensitizing composition for energetic hydrogen peroxide emulsions
Inventor: GUSTAVSSON THOMAS
IPC: C06B23/00
Filed: 2022-05-04
Abstract: A sensitizing composition for generating gas bubbles in an energetic hydrogen peroxide emulsion is disclosed. The sensitizing composition comprises a liquid carrier, a solid hydrogen peroxide catalyst which is dispersed in the liquid carrier and; a coating agent which is non-soluble in hydrogen peroxide and in water and which is arranged to coat the solid hydrogen peroxide catalyst dispersed in the liquid carrier. A method of preparing such a sensitizing composition is also disclosed.
Patent AU-2022279517-A1 (AU)
Title: Automated drug delivery systems and methods
Inventor: ANAND P J
IPC: A61M5/145
Filed: 2022-12-01
Abstract: AUTOMATED DRUG DELIVERY SYSTEMS AND METHODS 
ABSTRACT 
Automated drug delivery systems and related methods are disclosed herein. In some 
embodiments, these sys- tems can reduce or eliminate infusion inconsistencies. An exem
plary system can include a syringe actuator which can be con- trolled via electrical, 
mechanical, pneumatic, and/or hydraulic means to precisely infuse and/or withdraw material 
from a patient.
Patent AU-2022280063-A1 (AU)
Title: Chimeric antigen receptor to target hla-g-positive cancers
Inventor: REZVANI KATY
IPC: C07K14/705
Filed: 2022-05-26
Abstract: Embodiments of the disclosure include methods and compositions related to targeting of HLA-G-expressing cells with particular engineered receptors. In specific embodimetns, NK cells are specifically engineered to bind HLA-G using particular chimeric antigen receptor constructs. In certain embodiments, vectors that express the HLA-G-targeting CARs also express particular a suicide gene and/or one or more particular cytokines.
Patent AU-2022283611-A1 (AU)
Title: Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
Inventor: Wang xiaozhao
IPC: A61P25/00
Filed: 2022-12-05
Abstract: This application relates to compounds of Formula (I) or pharmaceutically acceptable salts or 
stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes 
A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of 
adenosine receptors including, for example, cancer, inflammatory disease, cardiovascular 
diseases, and neurodegenerative diseases.
Patent AU-2022285805-A1 (AU)
Title: Microbiocidal tetrahydroisoquinoline derivatives
Inventor: SCARBOROUGH CHRISTOPHER CHARLES
IPC: A01N43/56
Filed: 2022-05-24
Abstract: A compound of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, which can be used as fungicides.
Patent AU-2022306256-A1 (AU)
Title: Anchor assembly
Inventor: WHITE SAMUEL
IPC: F16B13/08
Filed: 2022-07-04
Abstract: There is provided an anchor assembly (10) and an insertion device (14) for an anchor (12). The anchor assembly (10) comprises the anchor (14) mountable on a support (22), the anchor (14) comprising a body (16), the body (16) defining a cavity (18) and an opening (42). The assembly (10) further includes the insertion device (14) insertable into the cavity (18) via the opening (42). The insertion device (14) comprises a securing member (46) movable between securing and insertion positions.
Patent AU-2022314729-A1 (AU)
Title: Sulfonimidamde compounds and uses thereof
Inventor: LAI KWONG WAH
IPC: C07D498/04
Filed: 2022-07-15
Abstract: Described herein are sulfonimidamide compounds, solvates thereof, tautomers thereof, and pharmaceutically acceptable salts of the foregoing. Further described herein are methods of treating a disorder in a subject in need thereof using said compounds, solvates, tautomers, or pharmaceutically acceptable salts thereof, such as NLRP3-mediated disorders.
Patent AU-2022397628-A1 (AU)
Title: Interaction method and apparatus, electronic device, and storage medium
Inventor: CHANG WEIYI
IPC: G06F9/451
Filed: 2022-11-10
Abstract: An interaction method and apparatus, an electronic device, and a storage medium. The interaction method comprises: displaying a target object in a first display mode on a target object display page, the target object display page under the first display mode comprising a first interaction control (S10); receiving a display mode switching operation on the target object display page (S20); and in response to the display mode switching operation, converting to displaying the target object in a second display mode on the target object display page, the target object display page under the second display mode comprising a second interaction control different from the first interaction control (S30). The method implements a diversified interaction function under different display modes.
Patent AU-2023200496-A1 (AU)
Title: Analyte detection apparatus and method of detecting an analyte
Inventor: BANKE STEFAN OVESEN
IPC: G01J3/02
Filed: 2023-01-31
Abstract: Analyte Detection Apparatus and 
Method of Detecting an Analyte 
The invention provides an analyte detection apparatus and method, the apparatus comprising a 
radiation source for irradiating a sample; a receiver, to receive an optical Raman spectrum of 
radiation transmitted back from the sample in response to the received radiation from the source, 
wherein the receiver comprises a plurality of different types of analysis device each arranged to 
receive a selected part of the received optical spectrum transmitted back from the sample.
Patent AU-2023200941-A1 (AU)
Title: Liquid protein formulations containing organophosphates
Inventor: LANGER ROBERT S
IPC: A61K47/24
Filed: 2023-02-17
Abstract: The present invention is directed to liquid pharmaceutical formulations for injection, wherein the 
formulations comprise one or more proteins, one or more viscosity-reducing organophosphates and a 
pharmaceutically acceptable solvent. The formulation has a viscosity from about 1 cP to about 50 cP at 250C 
measured using a cone and plate viscometer. The absolute viscosity of this formulation is less than the 
absolute viscosity of the otherwise same formulation comprising an equivalent amount of sodium 
phosphate in place of the organophosphate, and wherein the absolute viscosity in each case is an 
extrapolated zero-shear viscosity. The formulations comprise high molecular weight proteins such as 
monoclonal antibodies.
Patent AU-2023208166-A1 (AU)
Title: Bispecific binding proteins and uses thereof
Inventor: KASTURIRANGAN SRINATH
IPC: C07K16/18
Filed: 2023-07-27
Abstract: The disclosure generally provides proteins that bind two epitopes (e.g., a first and a second 
epitope) and that are bivalent for binding to each of the first and second epitopes. The 
disclosure also provides for specific binding proteins, including antibodies, which bind to a 
target protein. The disclosure also provides compositions comprising such proteins, nucleic 
acid molecules encoding such proteins and methods of making such proteins. The disclosure 
provides methods of inducing an immune response in a subject as well as methods for treating 
or preventing cancer in a subject by administering the proteins, nucleic acid molecules and/or 
compositions to the subject.
Patent AU-2023222923-A1 (AU)
Title: Laundry treating apparatus
Inventor: JUNG SUNGWOON
IPC: D06F39/02
Filed: 2023-08-31
Abstract: A laundry treating apparatus comprises a cabinet, a tub, a drum, and a detergent 
feeder. The detergent feeder comprises a storage unit, a supply casing, and a water supply 
unit, where the storage unit is inserted into the cabinet through the detergent opening and 
comprises therein a storage space for storing detergent therein. The supply casing 
accommodates the storage unit therein. The water supply unit is configured to supply water 
to the storage unit and comprises a water supply portion for supplying water to the storage 
unit, a shower portion for supplying water into the supply casing by avoiding the storage 
unit, and a shower flow channel extending from the water supply portion and connected to 
the shower portion to deliver water from the water supply portion to the shower portion.